These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30414384)

  • 21. [Interim analysis in clinical trials: a methodological guide].
    Muñoz Navarro SR; Bangdiwala SI
    Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interim analyses and early termination of clinical trials.
    Choi SC
    J Biopharm Stat; 1997 Nov; 7(4):533-43. PubMed ID: 9358327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing superiority at interim analyses in a non-inferiority trial.
    Chen YH; Chen C
    Stat Med; 2012 Jul; 31(15):1531-42. PubMed ID: 22438208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing a primary and a secondary endpoint in a group sequential design.
    Tamhane AC; Mehta CR; Liu L
    Biometrics; 2010 Dec; 66(4):1174-84. PubMed ID: 20337631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methods.
    Hulot JS; Cucherat M; Charlesworth A; Van Veldhuisen DJ; Corvol JC; Mallet A; Boissel JP; Hampton J; Lechat P
    Br J Clin Pharmacol; 2003 Mar; 55(3):299-306. PubMed ID: 12630981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of state of the art statistical methodology in biomedical research: the example of methodology for interim analyses in clinical trials].
    Muñoz SR; Bangdiwala SI
    Rev Med Chil; 2001 Sep; 129(9):983-8. PubMed ID: 11725478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interim monitoring of sequential multiple assignment randomized trials using partial information.
    Manschot C; Laber E; Davidian M
    Biometrics; 2023 Dec; 79(4):2881-2894. PubMed ID: 36896962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of logrank tests and group sequential methods at fixed calendar times.
    DeMets DL; Gail MH
    Biometrics; 1985 Dec; 41(4):1039-44. PubMed ID: 4096915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous sequential monitoring of efficacy and safety led to masking of effects.
    van Eekelen R; de Hoop E; van der Tweel I
    J Clin Epidemiol; 2016 Aug; 76():155-65. PubMed ID: 26944293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How much do we have to pay for how many interim analyses?
    Koch A
    Contemp Clin Trials; 2005 Feb; 26(1):113-6. PubMed ID: 15837456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the spending function method and the Christmas tree correction for group sequential trials.
    Stallard N; Facey KM
    J Biopharm Stat; 1996 Jul; 6(3):361-73. PubMed ID: 8854238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An additive boundary for group sequential designs with connection to conditional error.
    Xi D; Gallo P
    Stat Med; 2019 Oct; 38(23):4656-4669. PubMed ID: 31338847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated significance tests on accumulating survival data.
    Skovlund E
    J Clin Epidemiol; 1999 Nov; 52(11):1083-8. PubMed ID: 10527002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stopping guidelines for clinical trials with multiple treatments.
    Hughes MD
    Stat Med; 1993 May; 12(10):901-15. PubMed ID: 8337547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.
    Heritier S; Lô SN; Morgan CC
    Stat Med; 2011 Jun; 30(13):1541-54. PubMed ID: 21432887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis.
    Smith CL; Jin Y; Raddad E; McNearney TA; Ni X; Monteith D; Brown R; Deeg MA; Schnitzer T
    Pharm Stat; 2019 Jan; 18(1):39-53. PubMed ID: 30321909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.